Probiotical Exclusive Supply Agreement Extended
Filed with ASX · · 3 pages · English
Summary by 6ix AI
This extension allows both companies to continue their long-standing partnership as Biome expands its international presence. The agreement supports Biome's ongoing Australian manufacturing initiatives, which are progressing well. Blair Vega Norfolk, the Managing Director, emphasized the importance of this partnership for Biome's growth strategy.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Watch Biome Australia's latest callBiome Australia (ASX:BIO) Q1 2026 Earnings Call · Replay · Oct 22, 2025Read the transcript of Biome Australia (ASX:BIO) Q1 2026 Earnings CallEarlier from Biome Australia
- Patent Application Filed for Probiotic Strain BMB18
- Biome First Half FY26 Results and Highlights
- Appendix 4D & Half Yearly Report
- Ethics Approval Granted for BMB18 Human Clinical Trial
- Biome secures distribution with Fullscript Canada
Later from Biome Australia
- BMB18 clinical trial expands to dual site
- Biome Signs Australian Manufacturing Agreement
- FY26 Trading Update
- International Markets Presentation
- Biome to Launch in China
Follow Biome Australia into a list and get an email when it puts out news.
Follow Biome Australia